{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:36:51Z","timestamp":1788219411445,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04346-7","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T07:32:59Z","timestamp":1756452779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Refractory \u201cstatus dyskineticus\u201d in a child with post-herpes simplex virus 1\u00a0N-methyl-D-aspartate receptor encephalitis: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Alessandro","family":"Santagostino Barbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"De Grandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Giacomini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Buratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Micalizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Brisca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Micalizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Margherita","family":"Mancardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"4346_CR1","doi-asserted-by":"crossref","unstructured":"Gnann JW, Whitley RJ. Herpes simplex encephalitis: an update. Current Infectious Disease Reports. Current Medicine Group LLC 1, 2017;19.","DOI":"10.1007\/s11908-017-0568-7"},{"issue":"9","key":"4346_CR2","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","volume":"17","author":"T Armangue","year":"2018","unstructured":"Armangue T, Spatola M, Vlagea A, Mattozzi S, C\u00e1rceles-Cordon M, Martinez-Heras E, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol. 2018;17(9):760\u201372.","journal-title":"Lancet Neurol"},{"issue":"1","key":"4346_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/mds.25623","volume":"29","author":"SS Mohammad","year":"2014","unstructured":"Mohammad SS, Sinclair K, Pillai S, Merheb V, Aumann TD, Gill D, et al. Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor. Mov Disord. 2014;29(1):117\u201322.","journal-title":"Mov Disord"},{"issue":"4","key":"4346_CR4","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/brain\/awad419","volume":"147","author":"J Cleaver","year":"2024","unstructured":"Cleaver J, Jeffery K, Klenerman P, Lim M, Handunnetthi L, Irani SR, et al. The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity. Brain. 2024;147(4):1130\u201348.","journal-title":"Brain"},{"key":"4346_CR5","doi-asserted-by":"crossref","unstructured":"Ruiz-Lopez M, Fasano A. Rethinking status dystonicus. Movement Disorders. Volume 32. John Wiley and Sons Inc.; 2017. pp. 1667\u201376.","DOI":"10.1002\/mds.27207"},{"key":"4346_CR6","doi-asserted-by":"publisher","unstructured":"Lumsden DE, Lim M, Irani S. Letter to the editors: comment on status dystonicus in adult patients with anti-N-methyl-D-asparate-acid receptor encephalitis. J Neurol. 2023;270(7):3630\u20131. https:\/\/doi.org\/10.1007\/s00415-023-11670-w","DOI":"10.1007\/s00415-023-11670-w"},{"issue":"2","key":"4346_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mds.27291","volume":"33","author":"DE Lumsden","year":"2018","unstructured":"Lumsden DE, Allen NM. Rethinking status dystonicus: a welcome start to a challenging problem. Mov Disord. 2018;33(2):344.","journal-title":"Mov Disord"},{"issue":"6","key":"4346_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/08830738221081593","volume":"37","author":"AG Saini","year":"2022","unstructured":"Saini AG, Hassan I, Sharma K, Muralidharan J, Dhawan S, Saini L, et al. Status dystonicus in children: a cross-sectional study and review of literature. J Child Neurol. 2022;37(6):441\u201350.","journal-title":"J Child Neurol"},{"issue":"5","key":"4346_CR9","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s00415-023-11599-0","volume":"270","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Cui L, Chen W, Huang H, Liu G, Su Y, et al. Status dystonicus in adult patients with anti-N-methyl-d-aspartate-acid receptor encephalitis. J Neurol. 2023;270(5):2693\u2013701.","journal-title":"J Neurol"},{"issue":"1","key":"4346_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/apha.12614","volume":"216","author":"MW Cunningham","year":"2016","unstructured":"Cunningham MW, Cox CJ. Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond. Acta Physiol. 2016;216(1):90\u2013100.","journal-title":"Acta Physiol"},{"issue":"1","key":"4346_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12028-019-00875-5","volume":"32","author":"F Ali","year":"2020","unstructured":"Ali F, Wijdicks EF. Treatment of movement disorder emergencies in autoimmune encephalitis in the neurosciences ICU. Neurocrit Care. 2020;32(1):286\u201394.","journal-title":"Neurocrit Care"},{"key":"4346_CR12","doi-asserted-by":"crossref","unstructured":"Vogt LM, Yang K, Tse G, Quiroz V, Zaman Z, Wang L, et al. Recommendations for the management of initial and refractory pediatric status dystonicus. Movement Disorders. John Wiley and Sons Inc; 2024.","DOI":"10.1002\/mds.29794"},{"key":"4346_CR13","doi-asserted-by":"crossref","unstructured":"Alwaki A, Goshgarian C, Irshad K, Chandok A. Refractory dyskinetic movements associated with NMDA encephalitis (P3.032). Neurology. 2015;84(14\\_supplement):P3.032. https:\/\/www.neurology.org\/doi\/abs\/10.1212\/WNL.84.14_supplement.P3.032","DOI":"10.1212\/WNL.84.14_supplement.P3.032"},{"issue":"May","key":"4346_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.parkreldis.2019.07.023","volume":"66","author":"AR Tavasoli","year":"2019","unstructured":"Tavasoli AR, Shahidi G, Parvaresh M, Fasano A, Ashrafi MR, Hosseinpour S, et al. Deep brain stimulation in status dystonicus caused by anti-NMDA receptor encephalitis. Parkinsonism Relat Disord. 2019;66(May):255\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"4346_CR15","doi-asserted-by":"crossref","unstructured":"Nosadini M, Thomas T, Eyre M, Anlar B, Armangue T, Benseler SM et al. International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitis. Neurol Neuroimmunol Neuroinflamm. 2021;8(5).","DOI":"10.1212\/NXI.0000000000001052"},{"key":"4346_CR16","unstructured":"Bortezomib for treatment. Of therapy-refractory anti-NMDA receptor encephalitis center for neurodegenerative diseases. H. German. 2016."},{"issue":"7","key":"4346_CR17","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nm1763","volume":"14","author":"K Neubert","year":"2008","unstructured":"Neubert K, Meister S, Moser K, Weisel F, Maseda D, Amann K, et al. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med. 2008;14(7):748\u201355.","journal-title":"Nat Med"},{"issue":"2","key":"4346_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/bjh.13533","volume":"171","author":"M Miano","year":"2015","unstructured":"Miano M, Scalzone M, Perri K, Palmisani E, Caviglia I, Micalizzi C, et al. Mycophenolate mofetil and sirolimus as second or further line treatment in children with chronic refractory primitive or secondary autoimmune cytopenias: a single centre experience. Br J Haematol. 2015;171(2):247\u201353.","journal-title":"Br J Haematol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04346-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04346-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04346-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:01:41Z","timestamp":1757451701000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04346-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4346"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04346-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical standards of the 1964 Declaration of Helsinki ethical guidelines were followed. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical compliance statement"}},{"value":"Written informed consent was obtained from the patients\u2019 parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"368"}}